Aurora Cannabis Inc. is a leading company in the cannabis industry, primarily focused on the production and distribution of medical and recreational cannabis products
With a commitment to sustainability and innovation, the company cultivates a diverse range of cannabis strains and products, including dried flower, oils, and edibles, aimed at meeting the demands of consumers and patients alike. Aurora operates through a network of facilities and has established a strong presence in multiple international markets, working to advance the understanding and benefits of cannabis through research and development. The company is dedicated to promoting responsible usage and prioritizes quality and compliance within its operations.
Aurora Cannabis Inc. (NASDAQACB) (TSX: ACB), announced on Tuesday developments in cannabis science from Aurora's research and genetics facility, Aurora Coast."As a company committed to leading the way in terms of cannabis innovation, we are dedicated to putting patients first by harnessing the innovative solutions developed by our top researchers at Aurora Coast, our unique global research facility," Lana Culley, vice president of science and innovation at Aurora. "We strive to continuously raise the bar on product superiority and overall user experience so that we can deliver on our mission of providing patients with access to the very best medical cannabis."
Cannabis company Canopy Growth Corporation (TSX: WEED) (NASDAQCGC) is launching the award-winning California-grown Claybourne brand in Canada, via an exclusive licensing agreement. Canadian medical cannabis company Aurora Cannabis Inc. NASDAQ: ACBNASDAQACB)
Aurora's leadership in global medical cannabis and ability to capitalize on opportunities within rapidly growing markets such as Australia, Germany, Poland, and the UK was clearly demonstrated in Q2 and is expected to continue in Q3.
Aurora Cannabis together with MedReleaf Australia, announced on Wednesday an enhanced product range of premium medical cannabis oil in Australia. The Canadian medical cannabis giant said the new cannabis oils include a variety of cannabinoid ratios to suit diverse patient needs and are now available for physicians to prescribe.The new products allow doctors to tailor treatments more precisely.
